众兴菌业涨2.19%，成交额1.13亿元，主力资金净流入1416.81万元

Core Viewpoint - The stock of Zhongxing Mushroom Industry has shown significant growth this year, with a year-to-date increase of 104.40% and a recent surge in trading volume, indicating strong market interest and potential investment opportunities [1][2]. Financial Performance - For the period from January to September 2025, Zhongxing Mushroom Industry reported a revenue of 1.475 billion yuan, representing a year-on-year growth of 4.16% [2]. - The net profit attributable to shareholders for the same period was 204 million yuan, marking a substantial increase of 130.51% compared to the previous year [2]. - Cumulative cash dividends since the company's A-share listing amount to 583 million yuan, with 348 million yuan distributed over the last three years [2]. Stock Market Activity - As of November 5, the stock price reached 14.48 yuan per share, with a trading volume of 113 million yuan and a market capitalization of 5.694 billion yuan [1]. - The stock has experienced a net inflow of 14.168 million yuan from major funds, with significant buying activity observed [1]. - The stock has been listed on the "龙虎榜" (Dragon and Tiger List) once this year, with the last occurrence on September 12 [1]. Shareholder Structure - As of September 30, the number of shareholders decreased by 21.79% to 26,200, while the average number of circulating shares per person increased by 27.86% to 14,915 shares [2]. - Among the top ten circulating shareholders, Manulife Consumer Dividend Index A (008928) increased its holdings by 36,300 shares, while China Europe Agricultural Industry Mixed Fund A (022521) entered as a new shareholder with 2.826 million shares [2]. Business Overview - Zhongxing Mushroom Industry, established on November 18, 2005, and listed on June 26, 2015, specializes in the research, cultivation, and sales of edible mushrooms [1]. - The main revenue sources include Agaricus bisporus (63.04%) and Enoki mushrooms (35.32%), with minor contributions from other products [1].